课题基金 / 基金详情

Long term follow up study and prevention of ATL occurrence among HTLV-1 carriers : a nationwide cohort study

Long term follow up study and prevention of ATL occurrence among HTLV-1 carriers : a nationwide cohort study
HTLV-1携带者中ATL发生的长期随访研究和预防:一项全国性队列研究
批准号:
17015047
负责人:
山口 一成
金额:
$58.75万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2009

项目摘要

项目成果

山口 一成的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There are still 1.0 million HTLV-1 carriers in Japan. Definitive risk factors for ATL development from carrier status remain unclear. To investigate viral- and host-specific determinants of the development of ATL among HTLV-1 carriers. A nationwide cohort study for HTLV-1 carriers named the Joint Study on Predisposing Factors of ATL Development (JSPFAD) comprising of 41 institutions. Participants were HTLV-1 carriers who provided written informed consent. HTLV-1 proviral load (VL) and sIL-2R were measured annually. Demographic characteristics and clinical data were also collected annually. We evaluated 1218 HTLV-1 carriers (426 males and 792 females) who were enrolled during 2002-2008. VL at enrollment was significantly higher in males than females (median, 2.10 vs 1.39 copies/100PBMC), in those aged 40-49 and 50-59 yrs than that of those aged &lt ; 40 yrs (P=0.02 and 0.007, respectively), and in those with a family history of ATL than those without the history (median, 2.32 vs 1.33 copies/100PBMC) (P=0.005). During follow-up as of September 2009, 14 participants progressed to overt ATL. Their baseline VL was high (range, 4. 17-28.58 copies/100PBMC). None developed ATL among those with a baseline VL lower than &lt ; 4 copies/100PBMC. Multivariate Cox analyses indicated that not only a higher VL but also advanced age, family history of ATL, and first opportunity for HTLV-1 testing during treatment for other diseases were independent risk factors for progression of ATL from carrier status
期刊论文(64)
专著(0)
科研奖励(0)
会议论文
Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null)(NOD) mice.
将人嗜 T 淋巴细胞病毒 1 型携带者的外周血单核细胞移植到 NOD/SCID/gamma(null)(NOD) 小鼠中。
DOI: --
发表时间: 2007
期刊: Int J Cancer 121(10)
影响因子: --
作者: [Takajo I, Umeki K, Morishita K, Yamamoto I, Kubuki Y, Hatakeyama K, Kataoka H, Okayama A.]
通讯作者: Okayama A.
DOI: 10.1182/blood-2009-09-242347
发表时间: 2010-06-03
期刊: BLOOD
影响因子: 20.3
作者: [Takasaki, Yumi, Iwanaga, Masako, Tsukasaki, Kunihiro]
通讯作者: Tsukasaki, Kunihiro
Down-regulation of CDKN1A in adult T cell leukemia/lymphoma despite overexpression of CDKN1A in HTLV-1-infected cell lines.
尽管在 HTLV-1 感染的细胞系中 CDKN1A 过度表达,但成人 T 细胞白血病/淋巴瘤中 CDKN1A 下调。
DOI: --
发表时间: 2010
期刊: J Virol
影响因子: 5.4
作者: [Watanabe M, Nakahata S, Hamasaki M, Saito Y, Kawano Y, Hidaka T, Yamashita K, Umeki K, Taki T, Taniwaki M, Okayama A, Mori shita K]
通讯作者: Mori shita K
DOI: --
发表时间: 2008
期刊: Int J Hematol 88
影响因子: --
作者: [Uchimaru K, Nakamura Y, Tojo A, Watanabe T, Yamaguchi K.]
通讯作者: Yamaguchi K.
46
    ATL発症高危険群の長期追跡と発病予防の検討
    HTLV-I抗体陽性者の長期追跡
    • 批准号:
      09252102
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas (A)
    • 资助金额:
      $26.88万
    • 财政年份:
      1999
    • 负责人:
      山口 一成
    • 依托单位:
    HTLV-I抗体陽性者の長期追跡
    • 批准号:
      06280117
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $8.96万
    • 财政年份:
      1994
    • 负责人:
      山口 一成
    • 依托单位:
    HTLV-I感染症の病態の解明と治療への新しい試み
    • 批准号:
      01614529
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $6.4万
    • 财政年份:
      1989
    • 负责人:
      山口 一成
    • 依托单位:
    国内基金
    海外基金
    pH响应型靶向ATL@Fe-MOF@M纳米载体在胆囊癌双模式成像指导下光热/化学动力协同免疫治疗的研究
    遗传性感觉神经病中ATL3突变致轴索末梢内质网功能障碍的机制研究
    • 批准号:
      LZ23H090004
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      赵国华
    • 依托单位:
    拟南芥E3泛素连接酶ATL5调控种子寿命的作用机制研究
    • 批准号:
      32070349
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      陈喜文
    • 依托单位:
    拟南芥E3泛素连接酶ATL17调控脱落酸抑制主根生长的分子机制研究
    • 批准号:
      31870248
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2018
    • 负责人:
      郝福顺
    • 依托单位: